ClariVest Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

ClariVest Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.13M	Hold	28,149	–	–	0.12%	241
2024 Q2	$1.13M	Buy	+28,149	New	+$1.17M	0.12%	241
2020 Q1	–	Sell	-30,532	Closed	-$1.82M	–	774
2019 Q4	$1.82M	Sell	30,532 -20,437	-40%	-$1.26M	0.04%	256
2019 Q3	$3.01M	Sell	50,969 -600	-1%	-$38.3K	0.07%	208
2019 Q2	$3.33M	Sell	51,569 -500	-1%	-$32.3K	0.08%	202
2019 Q1	$3.31M	Sell	52,069 -19,469	-27%	-$1.02M	0.07%	235
2018 Q4	$2.72M	Buy	71,538 +34,421	+93%	+$1.22M	0.06%	254
2018 Q3	$1.59M	Buy	+37,117	New	+$1.3M	0.03%	358

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClariVest Asset Management's TNDM Position: Q3 2024 in Review

ClariVest Asset Management held its Tandem Diabetes Care (TNDM) position steady in Q3 2024 at 28,149 shares worth $1.13M. The position accounts for 0.12% of the portfolio, ranked #241.

ClariVest Asset Management first reported a position in TNDM in Q3 2018 and has held it in 8 quarters since. The position peaked at $3.33M in Q2 2019. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

ClariVest Asset Management held 28,149 shares of Tandem Diabetes Care worth $1.13M as of Q3 2024.
ClariVest Asset Management left its Tandem Diabetes Care share count unchanged in Q3 2024.
Tandem Diabetes Care made up 0.12% of ClariVest Asset Management's portfolio in Q3 2024, its #241 holding.
ClariVest Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 8 quarters since.
ClariVest Asset Management's Tandem Diabetes Care position peaked at $3.33M in Q2 2019.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.